WO1992019738A1 - Microbial degradation of trichloroethylene, dichloroethylenes and aromatic pollutants - Google Patents
Microbial degradation of trichloroethylene, dichloroethylenes and aromatic pollutants Download PDFInfo
- Publication number
- WO1992019738A1 WO1992019738A1 PCT/US1992/003515 US9203515W WO9219738A1 WO 1992019738 A1 WO1992019738 A1 WO 1992019738A1 US 9203515 W US9203515 W US 9203515W WO 9219738 A1 WO9219738 A1 WO 9219738A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hazardous chemicals
- chemicals
- group
- cepacia
- degrading
- Prior art date
Links
- 230000015556 catabolic process Effects 0.000 title claims abstract description 22
- 238000006731 degradation reaction Methods 0.000 title claims abstract description 19
- -1 trichloroethylene, dichloroethylenes Chemical class 0.000 title claims abstract description 6
- 125000003118 aryl group Chemical group 0.000 title claims description 16
- 239000003344 environmental pollutant Substances 0.000 title description 10
- 231100000719 pollutant Toxicity 0.000 title description 9
- 230000000813 microbial effect Effects 0.000 title description 5
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims abstract description 82
- 241000589513 Burkholderia cepacia Species 0.000 claims abstract description 38
- 239000000383 hazardous chemical Substances 0.000 claims abstract description 35
- 238000000034 method Methods 0.000 claims abstract description 30
- 230000000593 degrading effect Effects 0.000 claims abstract description 17
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims abstract description 15
- 230000008569 process Effects 0.000 claims abstract description 14
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims abstract description 12
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 claims abstract description 12
- QWVGKYWNOKOFNN-UHFFFAOYSA-N o-cresol Chemical compound CC1=CC=CC=C1O QWVGKYWNOKOFNN-UHFFFAOYSA-N 0.000 claims abstract description 10
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical group CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000011065 in-situ storage Methods 0.000 claims abstract description 8
- KFUSEUYYWQURPO-UPHRSURJSA-N cis-1,2-dichloroethene Chemical group Cl\C=C/Cl KFUSEUYYWQURPO-UPHRSURJSA-N 0.000 claims abstract description 5
- 229940078552 o-xylene Drugs 0.000 claims abstract description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 31
- 102000004190 Enzymes Human genes 0.000 claims description 29
- 108090000790 Enzymes Proteins 0.000 claims description 29
- 239000000126 substance Substances 0.000 claims description 20
- 150000003839 salts Chemical class 0.000 claims description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 10
- 229910052799 carbon Inorganic materials 0.000 claims description 10
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims description 7
- 230000001580 bacterial effect Effects 0.000 claims description 7
- 230000012010 growth Effects 0.000 claims description 7
- 239000001540 sodium lactate Substances 0.000 claims description 7
- 229940005581 sodium lactate Drugs 0.000 claims description 7
- 235000011088 sodium lactate Nutrition 0.000 claims description 7
- 239000000020 Nitrocellulose Substances 0.000 claims description 6
- 229920001220 nitrocellulos Polymers 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 5
- 230000013011 mating Effects 0.000 claims description 4
- 241000588724 Escherichia coli Species 0.000 claims description 3
- 239000001064 degrader Substances 0.000 claims description 3
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 claims description 3
- 229960002064 kanamycin sulfate Drugs 0.000 claims description 3
- 239000002699 waste material Substances 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 238000002703 mutagenesis Methods 0.000 claims description 2
- 231100000350 mutagenesis Toxicity 0.000 claims description 2
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 claims 2
- 241000894006 Bacteria Species 0.000 abstract description 14
- 150000001875 compounds Chemical class 0.000 abstract description 7
- KFUSEUYYWQURPO-OWOJBTEDSA-N trans-1,2-dichloroethene Chemical group Cl\C=C\Cl KFUSEUYYWQURPO-OWOJBTEDSA-N 0.000 abstract description 3
- 150000005829 chemical entities Chemical class 0.000 abstract 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 40
- UBOXGVDOUJQMTN-UHFFFAOYSA-N trichloroethylene Natural products ClCC(Cl)Cl UBOXGVDOUJQMTN-UHFFFAOYSA-N 0.000 description 38
- 210000004027 cell Anatomy 0.000 description 20
- UGEJOEBBMPOJMT-UHFFFAOYSA-N 3-(trifluoromethyl)phenol Chemical compound OC1=CC=CC(C(F)(F)F)=C1 UGEJOEBBMPOJMT-UHFFFAOYSA-N 0.000 description 18
- 230000000694 effects Effects 0.000 description 13
- 239000000758 substrate Substances 0.000 description 13
- 239000002609 medium Substances 0.000 description 11
- PGSWEKYNAOWQDF-UHFFFAOYSA-N 3-methylcatechol Chemical compound CC1=CC=CC(O)=C1O PGSWEKYNAOWQDF-UHFFFAOYSA-N 0.000 description 10
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 9
- 230000007613 environmental effect Effects 0.000 description 9
- 239000000411 inducer Substances 0.000 description 9
- 230000002103 transcriptional effect Effects 0.000 description 9
- 230000010076 replication Effects 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 230000002860 competitive effect Effects 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- LGXVIGDEPROXKC-UHFFFAOYSA-N 1,1-dichloroethene Chemical group ClC(Cl)=C LGXVIGDEPROXKC-UHFFFAOYSA-N 0.000 description 5
- MTOBWJUHQXQURZ-ZPUQHVIOSA-N 2-hydroxymuconate semialdehyde Chemical compound O\C=C\C=C\C(=O)C(O)=O MTOBWJUHQXQURZ-ZPUQHVIOSA-N 0.000 description 5
- 229930027917 kanamycin Natural products 0.000 description 5
- 229960000318 kanamycin Drugs 0.000 description 5
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 5
- 229930182823 kanamycin A Natural products 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 230000037361 pathway Effects 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 4
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 238000012423 maintenance Methods 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 238000005067 remediation Methods 0.000 description 4
- 108010080972 Catechol 2,3-dioxygenase Proteins 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical group ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000003413 degradative effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229940001447 lactate Drugs 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000002957 persistent organic pollutant Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 101150040611 tomB gene Proteins 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 239000003039 volatile agent Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- HVZGWILTESYJSP-UHFFFAOYSA-N 2-hydroxy-6-oxo-2,4-heptadienoic acid Chemical compound CC(=O)C=CC=C(O)C(O)=O HVZGWILTESYJSP-UHFFFAOYSA-N 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000000589 Siderophore Substances 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 230000003466 anti-cipated effect Effects 0.000 description 2
- 230000001925 catabolic effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000002920 hazardous waste Substances 0.000 description 2
- 230000033444 hydroxylation Effects 0.000 description 2
- 238000005805 hydroxylation reaction Methods 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- IVSZLXZYQVIEFR-UHFFFAOYSA-N m-xylene Chemical group CC1=CC=CC(C)=C1 IVSZLXZYQVIEFR-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 230000008488 polyadenylation Effects 0.000 description 2
- YNCMLFHHXWETLD-UHFFFAOYSA-N pyocyanin Chemical compound CN1C2=CC=CC=C2N=C2C1=CC=CC2=O YNCMLFHHXWETLD-UHFFFAOYSA-N 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000006152 selective media Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229950011008 tetrachloroethylene Drugs 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 229960002415 trichloroethylene Drugs 0.000 description 2
- GBYOHSZBFWOXHR-TZFCGSKZSA-N (2Z,4E)-7,7,7-trifluoro-2-hydroxy-6-oxohepta-2,4-dienoic acid Chemical compound OC(=O)C(\O)=C\C=C\C(=O)C(F)(F)F GBYOHSZBFWOXHR-TZFCGSKZSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- WTLKTXIHIHFSGU-UHFFFAOYSA-N 2-nitrosoguanidine Chemical compound NC(N)=NN=O WTLKTXIHIHFSGU-UHFFFAOYSA-N 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 108010082340 Arginine deiminase Proteins 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 108010028143 Dioxygenases Proteins 0.000 description 1
- 102000016680 Dioxygenases Human genes 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 101150082479 GAL gene Proteins 0.000 description 1
- 102000013382 Gelatinases Human genes 0.000 description 1
- 108010026132 Gelatinases Proteins 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- SRBFZHDQGSBBOR-OWMBCFKOSA-N L-ribopyranose Chemical compound O[C@H]1COC(O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-OWMBCFKOSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 108090000417 Oxygenases Proteins 0.000 description 1
- 102000004020 Oxygenases Human genes 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000364057 Peoria Species 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 241000947836 Pseudomonadaceae Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589776 Pseudomonas putida Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 241001148470 aerobic bacillus Species 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000006652 catabolic pathway Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 231100000481 chemical toxicant Toxicity 0.000 description 1
- 239000002894 chemical waste Substances 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000012411 cloning technique Methods 0.000 description 1
- 230000006957 competitive inhibition Effects 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000005264 electron capture Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940093496 esculin Drugs 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000012632 extractable Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003673 groundwater Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 229960002160 maltose Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000001450 methanotrophic effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QVGXLLKOCUKJST-NJFSPNSNSA-N oxygen-18 atom Chemical compound [18O] QVGXLLKOCUKJST-NJFSPNSNSA-N 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 229940049953 phenylacetate Drugs 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000903 polyhydroxyalkanoate Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 238000003385 ring cleavage reaction Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- 101150035767 trp gene Proteins 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- MECFLMNXIXDIOF-UHFFFAOYSA-L zinc;dibutoxy-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [Zn+2].CCCCOP([S-])(=S)OCCCC.CCCCOP([S-])(=S)OCCCC MECFLMNXIXDIOF-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F3/00—Biological treatment of water, waste water, or sewage
- C02F3/02—Aerobic processes
- C02F3/12—Activated sludge processes
- C02F3/1205—Particular type of activated sludge processes
- C02F3/1231—Treatments of toxic sewage
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F3/00—Biological treatment of water, waste water, or sewage
- C02F3/34—Biological treatment of water, waste water, or sewage characterised by the microorganisms used
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/38—Pseudomonas
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02W—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
- Y02W10/00—Technologies for wastewater treatment
- Y02W10/10—Biological treatment of water, waste water, or sewage
Definitions
- TCE trichloroethylene
- TCE transformation by anaerobic bacteria indicate a very slow process.
- the rapid mineralization of TCE by aerobic bacteria has been demonstrated for several microbial isolates. All require the addition of exogenous chemicals to induce production of the requisite TCE degrading enzymes.
- Toluene serves to induce oxygenase enzymes of Pseudomonas putida
- cepacia G4 has been shown to proceed via a monooxygenation pathway that results first in an ortho- hydroxylation of toluene (catalyzed by _-toluene monooxygenase) and subsequently a second hydroxylation ortho to the first hydroxyl to form 3- methylcatechol (Shields, M.S., S.O. Montgomery, P . Chapman, S.M. Cuskey, and P.H. Pritchard. 1989. Appl. Environ. Microbiol. 55:1624-1629).
- U.S. 4,749,491 concerns a method for stimulating indigenous bacteria to degrade chlorinated hydrocarbons through the addition of oxygen and propane or methane.
- U.S. 4,664,805 concerns a method for degradation of halogenated organic pollutants through the addition of non-toxic chemical analogs with or without non-indigenous microorganisms.
- U.S. 4,452,894 concerns a pure culture of a Pseudomonas spp. that can utilize a variety of chlorinated aromatic chemicals as sole sources of carbon.
- U.S. 4,477,570 concerns the isolation of bacterial strains, specifically Pseudomonas cepacia var. niagarous, that degrade aromatic and halogenated aromatic chemicals.
- U.S. 4,954,258 concerns the additiona of alkanes or lower alkanols to methanotrophic bacteria for the degradation of TCE.
- U.S. 4,925,802 concerns a method for stimulating biodegradation of halogenated aliphatic hydrocarbons.
- the method uses microbes and an inducer. Specifically exemplified is the non-constitutive microbe, Pseudomonas cepacia strain G4, which is the parent of the constitutive microbe strain of the subject invention.
- TCE is necessarily linked to the production of an enzyme that can accept TCE as a surrogate substrate, the native substrate being that which is used to induce the enzyme's synthesis. Due to this co-metabolic relationship, TCE cannot be degraded in the environment without the addition of an exogenous inducing substrate, because TCE does not itself induce the enzymes required for its own degradation. As a result, these prior art organisms are faced with the additional limitation of degrading TCE in the presence of the required co- substrate that competes for the same active site on the induced enzyme. In addition, this also means that the organisms are not active beyond the environmental zone that can be controlled through the addition of effective concentrations of inducer. The active bacteria are effectively "tethered" to the inducing substrate. Both of these limitations have serious implications to the design of both environmental and bioreactor applications. In addition, the application of native inducing substrates such as toluene or phenol is not possible in the environment as they are themselves pollutants.
- the use of the microbe of the subject invention advantageously, does not have the problems associated with the use of prior art microbes to remediate sites contaminated with hazardous chemicals.
- the microbe of the invention P. cepacia strain G45223 Phe (1), is a natural bacterial isolate that can function over a wide range of environmental conditions without the need for an added chemical inducer; it has a very high likelihood of competitive maintenance among native bacteria over the course of a given treatment; and it has evolved to utilize and grow on many organic pollutants likely to be found at waste treatment sites.
- the subject invention concerns the use of a novel bacterial strain to degrade TCE over a wide range of environmental parameters without the requirement for added chemical inducers.
- the subject invention concerns the use of the novel strain designated Pseudomonas cepacia strain G4 5223 Phe (1) to degrade hazardous chemicals, for example, trichloroethylene (TCE), cis-1,2- dichloroethylene, trans-l,2-dichloroethylene, 1,1-dichloroethylene, and aromatic chemicals, for example benzene, phenol, toluene, o-xylene, m-xylene, o-cresol, and m-cresol.
- TCE trichloroethylene
- trans-l,2-dichloroethylene 1,1-dichloroethylene
- aromatic chemicals for example benzene, phenol, toluene, o-xylene, m-xylene, o-cresol, and m-cresol.
- the novel bacterium is fully capable of the complete removal of the aforementioned pollutants under a variety of conditions, without the need to artificially or externally influence existing
- this novel bacterium is an attractive biodegradative agent for remediation of TCE pollution for two reasons. First, and most importantly, the organism is free of the requirement of inducer and capable of functioning under a diverse set of conditions. Second, this constitutive degrader does not require an inducer that is a co-substrate for the same enzyme required to degrade TCE; in effect, it is not subject to competitive inhibition. As such, it can be used in both in situ environmental and bioreactor remediation processes.
- the subject invention also includes the genes(s) harbored by the novel bacterium which gene(s) encode enzyme(s) capable of degrading the hazardous chemicals.
- gene(s) can be isolated from the parent bacterium by using well-known cloning techniques.
- the isolated gene(s) can be used to transform other microbes by use of well-known transfer and expression vectors.
- the transformed host can be used in the same manner as the parent microbe to degrade hazardous chemical compounds.
- the enzyme(s) responsible for the degradation of the hazardous chemical compounds can be recovered from the extracts of cultures of the novel bacterium and used to degrade hazardous chemical compounds by procedures well known in the art.
- Figure 1 Illustrates the first two oxidations performed on toluene by P. cepacia G4.
- Figure 2 A presentation of the probable route of oxidation of the m- cresol analog: 3-trifluoromethylphenol (TFMP) to the yellow ring-cleavage product.
- TFMP 3-trifluoromethylphenol
- FIG 3 A portrayal of the known catabolic transformations associated with the initial enzymes of toluene catabolism in P. cepacia G4.
- FIG. 4 The effects of several environmental variables on the initial (i.e., over the first 1-2 hr) rate of TCE degradation by P. cepacia G4 5223 are shown.
- accession number is as follows:
- the taxonomy of Pseudomonas cepacia strain G4 5223 Phe(l) is as follows:
- Pseudomonas cepacia G4 5223 Phe(l) is an oxidase-positive and catalase-positive gram-negative obligately aerobic rod. It reduces nitrate to nitrite, is incapable of denitrification, and is unable to ferment glucose or hydrolyze esculin. Tests for urease, gelatinase, and arginine dihydrolase activity were negative.
- Beta-galactosidase activity is present and substrate utilization tests showed growth on D-glucose, D-arabinose, D-mannose, mannitol, N- acetyl-D-glucosamine, maltose, gluconate, caprate, adipate, citrate, and phenylacetate. L-malate is not utilized. Neither pyocyanin or fluorescein pigments are formed on selective media (King, E.O., M.K. Ward, and D.E. Raney. 1954. J. Lab. Clin. Med. 44:301). Pseudomonas cepacia G4 5223 Phe(l) is resistant to kanamycin sulfate (50 ⁇ g/ml) in basal salts medium
- the procedure of application of P. cepacia G4 5223 Phe(l) to the remediation of TCE-contaminated materials may be carried out through the use of various known procedures.
- the organism may be used in a bioreatcor (fixed film, fluidized bed, etc.) as well as in situ by methods generally such as those disclosed in U.S. Patent Nos. 4,749,491 and 4,588,506.
- Enzyme(s) produced by the novel microbe of the invention can be recovered from the cultured cells of the microbe.
- the recovery process can be one in which the microbial cells at harvest are extracted and the enzyme(s) recovered by standard procedures.
- the resulting enzyme preparation can be used to degrade hazardous chemicals, as disclosed herein.
- the treatment of hazaradous chemicals with an enzyme preparation can be by use of columns and other means well known in the enzyme art.
- the enzyme preparation so used can be in either a crude or essentially pure form.
- Novel recombinant microbes can be made by isolating the gene(s) from
- the gene(s) encode enzymes which are capable of degrading hazardous chemical compounds.
- a wide variety of ways are available for introducing a gene into a microorganism host under conditions which allow for stable maintenance and expression of the gene.
- Various manipulations may be employed for enhancing the expression of the messenger RNA, particularly by using an active promoter, as well as by employing sequences, which enhance the stability of the messenger RNA.
- the transcriptional and translational termination region will involve stop codon(s), a terminator region, and optionally, a polyadenylation signal.
- the construct will involve the transcriptional regulatory region, if any, and the promoter, where the regulatory region may be either 5' or 3' of the promoter, the ribosomal binding site, the initiation codon, the structural gene having an open reading frame in phase with the initiation codon, the stop codon(s), the polyadenylation signal sequence, if any, and the terminator region.
- This sequence as a double strand may be used by itself for transformation of a microorganism host, but will usually be included with a DNA sequence involving a marker, where the second DNA sequence may be joined to the expression construct during introduction of the DNA into the host.
- a marker structural gene is used to provide for the selection of the host microbe which has acquired the desired nucleotide sequence. (via, for example, transformation, electroporation, conjugation, or phage mediated).
- the marker will normally provide for selective advantage, for example, providing for biocide resistance, e.g., resistance to antibiotics or heavy metals; complementation, so as to provide, prototrophy to an auxotrophic host, or the like.
- complementation is employed, so that the modified host may not only be selected, but may also be competitive in the field.
- One or more markers may be employed in the development of the constructs, as well as for modifying the host.
- the organisms may be further modified by providing for a competitive advantage against other wild-type microorganisms in the field.
- genes expressing metal chelating agents may be introduced into the host along with the structural gene.
- the enhanced expression of a siderophore may provide for a competitive advantage for the host, so that it may effectively compete with wild-type microorganisms.
- the construct will also include a sequence of at least 50 basepairs (bp), preferably at least about 100 bp, and usually not more than about 1000 bp of a sequence homologous with a sequence in the host.
- bp basepairs
- the gene will be in close proximity to the gene providing for complementation as well as the gene providing for the competitive advantage. Therefore, in the event that a gene is lost, the resulting organism will be likely to also lose the complementing gene and/or the gene providing for the competitive advantage, so that it will be unable to compete in the environment with the organism retaining the intact construct.
- transcriptional regulatory regions are available from a wide variety of microorganism hosts, such as bacteria, bacteriophage, cyanobacteria, algae, fungi, and the like.
- Various transcriptional regulatory regions include the regions associated with the trp gene, lac gene, gal gene, the lambda left and right promoters, the Tac promoter, the naturally-occurring promoters associated with the gene, where functional in the host.
- the termination region may be the termination region normally associated with the transcriptional termination region or a different transcriptional termination region, so long as the two regions are compatible and functional in the host. Where stable episomal maintenance or integration is desired, a plasmid will be employed which has a replication system which is functional in the host.
- the replication system may be derived from the chromosome, an episomal element normally present in the host or a different host, or a replication system from a virus which is stable in the host.
- the gene can be introduced between the transcriptional and translational initiation region and the transcriptional and translational termination region, so as to be under the regulatory control of the initiation region.
- This construct will be included in a plasmid, which will include at least one replication system, but may include more than one, where one replication system is employed for cloning during the development of the plasmid and the second replication system is necessary for functioning in the ultimate host.
- one or more markers may be present, which have been described previously.
- the plasmid will desirably include a sequence homologous with the host genome.
- the transformants can be isolated in accordance with conventional ways, usually employing a selection technique, which allows for selection of the desired organism as against unmodified organisms or transferring organisms, when present. The transformants then can be tested for degrading hazardous chemical compounds.
- Suitable host cells can be Gram-negative bacteria, including Enterobacteriaceae, such as Escherichia. and other Pseudomonadaceae.
- the recombinant cellular host containing the gene(s) may be grown in any convenient nutrient medium, where the DNA construct provides a selective advantage, providing for a selective medium so that substantially all or all of the cells retain the gene. These cells may then be harvested in accordance with conventional ways.
- Mutants of this pathway were detectable in the presence of the fluorinated analog of m-cresol; m-trifluoromethylphenol (TFMP) (Aldrich Chemical Co., Milwaukee, WI). Wild type cells were capable of the oxidation of TFMP to a bright yellow transformation product presumed to be 7,7,7- trifluoro-2-hydroxy-6-oxo-2,4-heptadienoic acid (Engesser, K.H., R.B. Cain, and HJ. Knackmuss. 1988. Arch. Microbiol. 149:188-197). Due to anticipated structural similarities between TFMP oxidation products and intermediates of the toluene pathway, it was predicted that mutants failing to produce yellow color with TFMP would lack either the cresol monooxidation or catechol dioxygenation functions. See Figure 2.
- Mutants were characterized according to their ability to grow with different aromatic substances and their reaction with TFMP as shown in Table 1. Table 1. Mutant Phenotypes
- Enzyme activities were derived from lactate grown cells following 6 hours exposure to air-entrained toluene vapor. Cell free extracts were analyzed for catechol-2,3-dioxygenase (Gibson, D.T. 1971. pg. 462-478. In D.J.R. Norris and D.W. Ribbons. Methods in Microbiology, 1971 Academic Press, New York), hydroxymuconic semialdehyde (Hms) hydrolase and Hms dehydrogenase activities (Bayly, R.C., and G.J. Wigmore. 1973. J. Bacteriol. 113:1112-1120).
- TCE Cells representative of the different mutant classes were induced using toluene and analyzed for their ability to degrade TCE. Washed cells were resuspended in basal salts medium containing 20 ⁇ M TCE to a cell density that yielded an absorbance at 600 nm of 0.2. These samples were sealed in 10ml glass vials with Teflon-lined rubber septa and crimp rings. These vials were incubated inverted at 24 degrees C overnight with rotary shaking (180 rpm). TCE was extracted by injection of two ml pentane (HPLC grade, Aldrich Chemical Co.) with rotary shaking in an upright position at 180 rpm, 24 degrees C for 30 minutes.
- the pentane phase was transferred to GC vials with Teflon liners and analyzed on an HP 5790 gas chromatograph equipped with an autosampler and electron capture detector. Separation was achieved with a Vocol capillary column, 30 m, 0.53 mm ID, fused silica, 3.0 ⁇ m film thickness (Supelco, Inc., Bellefonte, PA #2-5320) at 50 degrees C.
- strain G4 100R1 fully regained both its ability to express the toluene o-monooxygenase as well as degrade TCE.
- Example 3 Isolation of a Tn5 Induced Toluene Monooxygenase Mutant of P. Cepacia G4
- Transposon mutagenesis was carried by a triparental mating: E. coli JM109 (pRZ102) (Jorgensen, R.A., S.J. Rothstein, and W.S. Reznikoff. 1979. Molec. Genet. 177:65-72) X E. coli JM109 (pRK2013) (Figurski, D.H., and D.R. Helinski. 1979. Proc. Natl. Acad. Sci. USA. 76:1648-1652) X P. cepacia G4. Selection for P.
- cepacia G4 containing a transposed copy of Tn5 was accomplished by growth of the mating mixture on basal salts medium containing 20 mM sodium lactate and 50 ⁇ g/ml kanamycin sulfate. Exposure to toluene vapor induced the requisite enzymes for toluene catabolism. Colonies were transferred from the surface of the plate to nitrocellulose filters (0.45 ⁇ pore size, Schliecher and Schuell, Keene, NH) previously soaked in an aqueous solution of 5mM TFMP and air dried. Mutants tomA and tomB (i.e.
- Transposon (Tn5) mutants of tomA were inoculated by patching to basal salts plates containing 2 mM phenol as the sole carbon source. Rare colonies arising were picked to basal salts medium containing 20mM sodium lactate as the sole carbon source. These colonies were in turn pulled to nitrocellulose discs impregnated with TFMP (Example 3) and compared to wild type P. cepacia G4 similarly grown on this non-inducing medium. Colonies that became yellow were picked as potentially constitutive for tomA and tomB gene products. In this way P. cepacia strain G4 5223 Phe(l) was isolated. Table 4: TCE degradation without inducer
- the genetic stability of the invention strain was assessed by growing the cells under non-selective (i.e. basal salts medium with sodium lactate at 20 mM as the sole carbon source) and under selective conditions (i.e. the same medium containing in addition 50 ⁇ g kanamycin sulphate/ml) through serially diluted batch cultures, allowing 10 generations per transfer. Following the accumulation of ca. 100 generations, the resulting population of cells was tested for kanamycin resistance (in the non-selective group) and the ability to constitutively transform TFMP to a yellow product (both groups):
- Lactate-grown colonies were picked to lactate plates containing 50 ⁇ g/ml kanamycin. Those from 100 generations without selection exhibited 100% kanamycin resistance (150/150) as did those taken from kanamycin growth selection (75/75).
- Example 6 Contitutive Degradation of 1.1-Dichloroethylene. cis-1.2- Dichloroethylene. and trans-1.2-Dichloroethylene
- the range of chlorinated aliphatic substrates acted upon by P. cepacia G4 5223 Phe(l) was determined by the ability of cells to degrade 10 ⁇ M TCE, 1,1-Dichloroethylene, cis-l,2-Dichloroethylene, trans-L2-Dichloroethylene and tetrachloroethylene in 2 ml of basal salts medium without additional carbon sources in 10 ml Teflon lined vessels during an overnight incubation at 24 degrees C. Triplicate samples were analyzed by gas chromatography for appearance of detectable products as well as disappearance of parent compounds: Table 7: Chloroaliphatic substrates of P. cepacia G4 5223 Phef 1.
- a Percent substrate remaining as compared to uninoculated controls abbreviations: 1,1-DCE, 1,1-Dichloroethylene; cis-l,2-DCE, cis-1,2- Dichloroethylene; trans.-l,2-DCE, trans-l,2-Dichloroethylene; TCE, Trichloroethylene; PCE, Perchloroethylene; ND, Not Detectable. Starting concentration was 10 ⁇ M for all substrates. M indicates that a metabolite was detected using gas chromatography.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Environmental & Geological Engineering (AREA)
- Biodiversity & Conservation Biology (AREA)
- Hydrology & Water Resources (AREA)
- Water Supply & Treatment (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
A novel bacterium named Pseudomonas cepacia G4 5223 Phe(1) has the desirable property of constitutively degrading hazardous chemicals, for example trichloroethylene, 1,1-dichloroethylene, cis-1,2 dichloroethylene, trans-1,2-dichloroethylene, toluene, phenol, o-cresol, m-cresol, o-xylene, and benzene, to harmless chemical entities. This microbe, and mutants thereof which retain the constitutive degradation property of the parent, can be used in bioreactor and in situ processes for degrading hazardous chemical compounds.
Description
DESCRIPTION
MICROBIAL DEGRADATION OF TRICHLOROETHYLENE. DICHLOROETHYLENES AND AROMATIC POLLUTANTS
Background of the Invention Groundwater contamination by organic pollutants is a subject of major concern in the United States and, increasingly, the rest of the industrialized world. The sources of pollution are almost as numerous as the types of pollutants found. Sources range from agricultural uses, injection wells, underground storage tanks and hazardous waste sites, to illegal dumping in localities with no prior history of toxic chemical exposure. In monitoring chemical waste disposal sites within the United States, pollutants have been categorized according to the frequency of detection of certain chemical classes and specific chemicals within that class. The priority pollutants are divided into volatiles, acid extractables, pesticides and base/neutrals. Volatiles are the most frequently detected group, owing largely to their widespread use as solvents. The most often encountered components of these volatile chemical pollutants in 1986 were, in order of frequency, tri-chloroethylene, tetrachloroethylene, trans-1, 2-dichloroethylene, 1,1-dichloroethylene, (ranked first, second, third and fifth respectively of all volatiles detected (Rajagopal, R. 1986. Environ. Prof. 8:244-264). The most prevalent of these, trichloroethylene (TCE), has been in use since the 1940's, and the subject of environmental and human health concerns since its discovery in a contaminated aquifer in 1979 (Muntner, J.E., and S.P. Devries, 1987. Toxics Law Reporter, Jan. 14:874).
All reports of TCE transformation by anaerobic bacteria indicate a very slow process. The rapid mineralization of TCE by aerobic bacteria has been demonstrated for several microbial isolates. All require the addition of exogenous chemicals to induce production of the requisite TCE degrading enzymes. Toluene serves to induce oxygenase enzymes of Pseudomonas putida
Fl (Nelson, M.J.K., S.O. Montgomery, and P.H. Pritchard. 1988. App. Environ. Microbiol. 54:604-606) and P. cepacia G4 (Nelson, M.J.K., S.O.
Montgomery, E. J. O'Neill, and P.H. Pritchard. 1986. Appl. Environ. Microbiol. 42:383-384). These enzymes are in turn responsible for TCE degradation by these bacteria. The route of toluene catabolism by P. cepacia G4 has been shown to proceed via a monooxygenation pathway that results first in an ortho- hydroxylation of toluene (catalyzed by _-toluene monooxygenase) and subsequently a second hydroxylation ortho to the first hydroxyl to form 3- methylcatechol (Shields, M.S., S.O. Montgomery, P . Chapman, S.M. Cuskey, and P.H. Pritchard. 1989. Appl. Environ. Microbiol. 55:1624-1629).
U.S. Patents concerning bioremediation are as follow: 4,749,491; 4,452,894; 4,664,805; 4,477,570; 4,925,802; 4,954,258.
U.S. 4,749,491 concerns a method for stimulating indigenous bacteria to degrade chlorinated hydrocarbons through the addition of oxygen and propane or methane.
U.S. 4,664,805 concerns a method for degradation of halogenated organic pollutants through the addition of non-toxic chemical analogs with or without non-indigenous microorganisms.
U.S. 4,452,894 concerns a pure culture of a Pseudomonas spp. that can utilize a variety of chlorinated aromatic chemicals as sole sources of carbon. U.S. 4,477,570 concerns the isolation of bacterial strains, specifically Pseudomonas cepacia var. niagarous, that degrade aromatic and halogenated aromatic chemicals.
U.S. 4,954,258 concerns the additiona of alkanes or lower alkanols to methanotrophic bacteria for the degradation of TCE.
U.S. 4,925,802 concerns a method for stimulating biodegradation of halogenated aliphatic hydrocarbons. The method uses microbes and an inducer. Specifically exemplified is the non-constitutive microbe, Pseudomonas cepacia strain G4, which is the parent of the constitutive microbe strain of the subject invention.
Current technology for the treatment of TCE-contaminated soil and water has relied primarily upon pump-and-treat systems whereby TCE is distilled away from the water under vacuum, or alternatively is air-stripped and transferred onto an adsorbent such as charcoal. Recent reviews of this subject
strongly question whether this technology alone will ever be effective in the remediation of hazardous wastes like TCE, since even long term treatments have had only modest effects on pollutant concentrations (Travis, C.C., and C.B. Doty. 1990. Environ. Sci. Technol. 24:1464-1466). In either event, the result of such treatment is simply the transfer of the pollutant to an adsorbent or to the atmosphere. The capability to destroy the contaminant at the site would represent significant environmental and economic benefits. If realized, efficient bioremediation technologies would fill this need. Major limitations to the bacterial systems described in the prior art for the bioremediation of TCE is that they all degrade TCE fortuitously. That is to say their ability to alter
TCE is necessarily linked to the production of an enzyme that can accept TCE as a surrogate substrate, the native substrate being that which is used to induce the enzyme's synthesis. Due to this co-metabolic relationship, TCE cannot be degraded in the environment without the addition of an exogenous inducing substrate, because TCE does not itself induce the enzymes required for its own degradation. As a result, these prior art organisms are faced with the additional limitation of degrading TCE in the presence of the required co- substrate that competes for the same active site on the induced enzyme. In addition, this also means that the organisms are not active beyond the environmental zone that can be controlled through the addition of effective concentrations of inducer. The active bacteria are effectively "tethered" to the inducing substrate. Both of these limitations have serious implications to the design of both environmental and bioreactor applications. In addition, the application of native inducing substrates such as toluene or phenol is not possible in the environment as they are themselves pollutants.
The use of the microbe of the subject invention, advantageously, does not have the problems associated with the use of prior art microbes to remediate sites contaminated with hazardous chemicals. Briefly, the microbe of the invention, P. cepacia strain G45223 Phe (1), is a natural bacterial isolate that can function over a wide range of environmental conditions without the need for an added chemical inducer; it has a very high likelihood of competitive maintenance among native bacteria over the course of a given
treatment; and it has evolved to utilize and grow on many organic pollutants likely to be found at waste treatment sites.
Brief Summary of the Invention The subject invention concerns the use of a novel bacterial strain to degrade TCE over a wide range of environmental parameters without the requirement for added chemical inducers.
More specifically, the subject invention concerns the use of the novel strain designated Pseudomonas cepacia strain G4 5223 Phe (1) to degrade hazardous chemicals, for example, trichloroethylene (TCE), cis-1,2- dichloroethylene, trans-l,2-dichloroethylene, 1,1-dichloroethylene, and aromatic chemicals, for example benzene, phenol, toluene, o-xylene, m-xylene, o-cresol, and m-cresol. The novel bacterium is fully capable of the complete removal of the aforementioned pollutants under a variety of conditions, without the need to artificially or externally influence existing conditions (i.e. induce the requisite enzymes). Without the need for exogenous chemical inducers, this novel bacterium is an attractive biodegradative agent for remediation of TCE pollution for two reasons. First, and most importantly, the organism is free of the requirement of inducer and capable of functioning under a diverse set of conditions. Second, this constitutive degrader does not require an inducer that is a co-substrate for the same enzyme required to degrade TCE; in effect, it is not subject to competitive inhibition. As such, it can be used in both in situ environmental and bioreactor remediation processes.
The subject invention also includes the genes(s) harbored by the novel bacterium which gene(s) encode enzyme(s) capable of degrading the hazardous chemicals. These gene(s) can be isolated from the parent bacterium by using well-known cloning techniques. The isolated gene(s) can be used to transform other microbes by use of well-known transfer and expression vectors. The transformed host can be used in the same manner as the parent microbe to degrade hazardous chemical compounds. Further, the enzyme(s) responsible for the degradation of the hazardous chemical compounds can be recovered from the extracts of cultures of the novel
bacterium and used to degrade hazardous chemical compounds by procedures well known in the art.
Brief Description of the Drawings Figure 1 Illustrates the first two oxidations performed on toluene by P. cepacia G4.
Figure 2 A presentation of the probable route of oxidation of the m- cresol analog: 3-trifluoromethylphenol (TFMP) to the yellow ring-cleavage product.
Figure 3 A portrayal of the known catabolic transformations associated with the initial enzymes of toluene catabolism in P. cepacia G4.
Figure 4 The effects of several environmental variables on the initial (i.e., over the first 1-2 hr) rate of TCE degradation by P. cepacia G4 5223 are shown.
Detailed Disclosure of the Invention Upon contact with a culture of Pseudomonas cepacia strain G4 5223
Phe(l), or a mutant thereof which retains substantially the degradative capability of the parent bacterium, with a hazardous chemical, as defined herein, the hazardous chemical is degraded to a non-hazardous entity.
A subculture of P. cepacia strain G4 5223 Phe(l) has been deposited in the permanent collection of the Agricultural Research Service Culture
Collection, Peoria, Illinois. The accession number is as follows:
Pseudomonas cepacia strain G4 5223 Phe(l) NRRLB-18811
The taxonomy of Pseudomonas cepacia strain G4 5223 Phe(l) is as follows:
Pseudomonas cepacia G4 5223 Phe(l) is an oxidase-positive and catalase-positive gram-negative obligately aerobic rod. It reduces nitrate to nitrite, is incapable of denitrification, and is unable to ferment glucose or hydrolyze esculin. Tests for urease, gelatinase, and arginine dihydrolase activity were negative. Beta-galactosidase activity is present and substrate utilization tests showed growth on D-glucose, D-arabinose, D-mannose, mannitol, N-
acetyl-D-glucosamine, maltose, gluconate, caprate, adipate, citrate, and phenylacetate. L-malate is not utilized. Neither pyocyanin or fluorescein pigments are formed on selective media (King, E.O., M.K. Ward, and D.E. Raney. 1954. J. Lab. Clin. Med. 44:301). Pseudomonas cepacia G4 5223 Phe(l) is resistant to kanamycin sulfate (50μg/ml) in basal salts medium
(Hareland, W., R.L. Crawford, PJ. Chapman, and S. Dagley. 1975. J. Bacteriol 121:272-285) containing 20mM sodium lactate as the sole carbon source and is also capable of growth with penicillin G (5mg/ml) as the sole carbon source. In addition, its demonstrated ability to store excess carbon as a microbial polyhydroxyalkanoate polyester may offer an excellent method to prolong degradative functions under the most extreme conditions.
The procedure of application of P. cepacia G4 5223 Phe(l) to the remediation of TCE-contaminated materials may be carried out through the use of various known procedures. For example the organism may be used in a bioreatcor (fixed film, fluidized bed, etc.) as well as in situ by methods generally such as those disclosed in U.S. Patent Nos. 4,749,491 and 4,588,506. Enzyme(s) produced by the novel microbe of the invention can be recovered from the cultured cells of the microbe. The recovery process can be one in which the microbial cells at harvest are extracted and the enzyme(s) recovered by standard procedures. The resulting enzyme preparation can be used to degrade hazardous chemicals, as disclosed herein. The treatment of hazaradous chemicals with an enzyme preparation, as disclosed above, can be by use of columns and other means well known in the enzyme art. The enzyme preparation so used can be in either a crude or essentially pure form. Novel recombinant microbes can be made by isolating the gene(s) from
P. cepacia strain G4 5223 Phe(l) and transforming suitable hosts with the gene(s). The gene(s) encode enzymes which are capable of degrading hazardous chemical compounds.
A wide variety of ways are available for introducing a gene into a microorganism host under conditions which allow for stable maintenance and expression of the gene. One can provide for DNA constructs which include the transcriptional and translational regulatory signals for expression of the gene,
the gene under their regulatory control and a DNA sequence homologous with a sequence in the host organism, whereby integration will occur, and/or a replication system which is functional in the host, whereby integration or stable maintenance will occur. Various manipulations may be employed for enhancing the expression of the messenger RNA, particularly by using an active promoter, as well as by employing sequences, which enhance the stability of the messenger RNA. The transcriptional and translational termination region will involve stop codon(s), a terminator region, and optionally, a polyadenylation signal. In the direction of transcription, namely in the 5' to 3' direction of the coding or sense sequence, the construct will involve the transcriptional regulatory region, if any, and the promoter, where the regulatory region may be either 5' or 3' of the promoter, the ribosomal binding site, the initiation codon, the structural gene having an open reading frame in phase with the initiation codon, the stop codon(s), the polyadenylation signal sequence, if any, and the terminator region. This sequence as a double strand may be used by itself for transformation of a microorganism host, but will usually be included with a DNA sequence involving a marker, where the second DNA sequence may be joined to the expression construct during introduction of the DNA into the host.
A marker structural gene is used to provide for the selection of the host microbe which has acquired the desired nucleotide sequence. (via, for example, transformation, electroporation, conjugation, or phage mediated). The marker will normally provide for selective advantage, for example, providing for biocide resistance, e.g., resistance to antibiotics or heavy metals; complementation, so as to provide, prototrophy to an auxotrophic host, or the like. Preferably, complementation is employed, so that the modified host may not only be selected, but may also be competitive in the field. One or more markers may be employed in the development of the constructs, as well as for modifying the host. The organisms may be further modified by providing for a competitive advantage against other wild-type microorganisms in the field. For example, genes expressing metal chelating agents, e.g., siderophores, may be introduced
into the host along with the structural gene. In this manner, the enhanced expression of a siderophore may provide for a competitive advantage for the host, so that it may effectively compete with wild-type microorganisms.
Where no functional replication system is present, the construct will also include a sequence of at least 50 basepairs (bp), preferably at least about 100 bp, and usually not more than about 1000 bp of a sequence homologous with a sequence in the host. In this way, the probability of legitimate recombination is enhanced, so that the gene will be integrated into the host and stably maintained by the host. Desirably, the gene will be in close proximity to the gene providing for complementation as well as the gene providing for the competitive advantage. Therefore, in the event that a gene is lost, the resulting organism will be likely to also lose the complementing gene and/or the gene providing for the competitive advantage, so that it will be unable to compete in the environment with the organism retaining the intact construct. A large number of transcriptional regulatory regions are available from a wide variety of microorganism hosts, such as bacteria, bacteriophage, cyanobacteria, algae, fungi, and the like. Various transcriptional regulatory regions include the regions associated with the trp gene, lac gene, gal gene, the lambda left and right promoters, the Tac promoter, the naturally-occurring promoters associated with the gene, where functional in the host. The termination region may be the termination region normally associated with the transcriptional termination region or a different transcriptional termination region, so long as the two regions are compatible and functional in the host. Where stable episomal maintenance or integration is desired, a plasmid will be employed which has a replication system which is functional in the host.
The replication system may be derived from the chromosome, an episomal element normally present in the host or a different host, or a replication system from a virus which is stable in the host.
The gene can be introduced between the transcriptional and translational initiation region and the transcriptional and translational termination region, so as to be under the regulatory control of the initiation region. This construct will be included in a plasmid, which will include at least
one replication system, but may include more than one, where one replication system is employed for cloning during the development of the plasmid and the second replication system is necessary for functioning in the ultimate host. In addition, one or more markers may be present, which have been described previously. Where integration is desired, the plasmid will desirably include a sequence homologous with the host genome.
The transformants can be isolated in accordance with conventional ways, usually employing a selection technique, which allows for selection of the desired organism as against unmodified organisms or transferring organisms, when present. The transformants then can be tested for degrading hazardous chemical compounds.
Suitable host cells can be Gram-negative bacteria, including Enterobacteriaceae, such as Escherichia. and other Pseudomonadaceae.
The recombinant cellular host containing the gene(s) may be grown in any convenient nutrient medium, where the DNA construct provides a selective advantage, providing for a selective medium so that substantially all or all of the cells retain the gene. These cells may then be harvested in accordance with conventional ways.
Following are examples which illustrate procedures, including the best mode, for practicing the invention. These examples should not be construed as limiting. All percentages are by weight and all solvent mixture proportions are by volume unless otherwise noted.
Example 1: Aromatic degradative pathway of P. cepacia G4
The toluene catabolic pathway of P. cepacia G4 was established using mutants induced with nitrosoguanidine and heavy oxygen isotope incorporation into the catabolic products (Shields, M.S., S.O. Montgomery, PJ. Chapman,
S.M. Cuskey, and P.H. Pritchard. 1989. Appl. Environ. Microbiol. 55:1624- 1629). See Figure 1.
Mutants of this pathway were detectable in the presence of the fluorinated analog of m-cresol; m-trifluoromethylphenol (TFMP) (Aldrich
Chemical Co., Milwaukee, WI). Wild type cells were capable of the oxidation of TFMP to a bright yellow transformation product presumed to be 7,7,7- trifluoro-2-hydroxy-6-oxo-2,4-heptadienoic acid (Engesser, K.H., R.B. Cain, and HJ. Knackmuss. 1988. Arch. Microbiol. 149:188-197). Due to anticipated structural similarities between TFMP oxidation products and intermediates of the toluene pathway, it was predicted that mutants failing to produce yellow color with TFMP would lack either the cresol monooxidation or catechol dioxygenation functions. See Figure 2.
Mutants were characterized according to their ability to grow with different aromatic substances and their reaction with TFMP as shown in Table 1. Table 1. Mutant Phenotypes
product is indicated by "+". "Toluene (Tol), phenol(Phe), o-cresol (o-Cre) and m-cresol (m-Cre). TFMP conversion was not detectable in colonies due to accumulation of either brown (Br) or yellow (Ye) colored products formed in the presence of inducer. dVery slow growth (5-7 days for recognizable colonies).
These classes of mutants were further characterized and confirmed by examination of the effects of mutation on whole cell oxygen uptake in the presence of different substrates and by measurement of the specific activities of enzymes in cell free extracts as shown in Table 2. Table 2. Cell Free Enzyme Activities
cell- free extracts obtained from cells induced with toluene. bAbbreviations: C230, catechol-2,3-dioxygenase, Cat, catechol; 3mCat, 3- methylcatechol; Hms, hydroxymuconic semialdehyde; Hod, 2-hydroxy-6- ketohepta- 2,4-dienoate.
Enzyme activities were derived from lactate grown cells following 6 hours exposure to air-entrained toluene vapor. Cell free extracts were analyzed for catechol-2,3-dioxygenase (Gibson, D.T. 1971. pg. 462-478. In D.J.R. Norris and D.W. Ribbons. Methods in Microbiology, 1971 Academic Press, New York), hydroxymuconic semialdehyde (Hms) hydrolase and Hms dehydrogenase activities (Bayly, R.C., and G.J. Wigmore. 1973. J. Bacteriol. 113:1112-1120).
This allowed the summation of data into the form of this comprehensive aromatic pathway cluster of P. cepacia G4 as shown in Figure 3.
Example 2: Toluene o-Monooxygenase of P. cepacia G4 is Required for TCE Degradation
Cells representative of the different mutant classes were induced using toluene and analyzed for their ability to degrade TCE. Washed cells were resuspended in basal salts medium containing 20 μM TCE to a cell density that yielded an absorbance at 600 nm of 0.2. These samples were sealed in 10ml glass vials with Teflon-lined rubber septa and crimp rings. These vials were incubated inverted at 24 degrees C overnight with rotary shaking (180 rpm). TCE was extracted by injection of two ml pentane (HPLC grade, Aldrich Chemical Co.) with rotary shaking in an upright position at 180 rpm, 24 degrees C for 30 minutes. The pentane phase was transferred to GC vials with Teflon liners and analyzed on an HP 5790 gas chromatograph equipped with an autosampler and electron capture detector. Separation was achieved with a Vocol capillary column, 30 m, 0.53 mm ID, fused silica, 3.0 μm film thickness (Supelco, Inc., Bellefonte, PA #2-5320) at 50 degrees C.
Only the mutant impaired in its toluene monooxygenase activity, (tomA)-, failed to degrade TCE. The spontaneous revertant of this mutant: strain G4 100R1 fully regained both its ability to express the toluene o-monooxygenase as well as degrade TCE.
Table 3: TCE degradation by cells induced with Phenol or Toluene
aMeans of triplicate TCE determinations (± standard deviation) after 24 h, using either toluene- (Tol) or phenol- (Phe) induced cultures. bPhenol or toluene induction of G4 was accomplished by exposing an overnight 20 mM lactate culture to 2 mM phenol or toluene. Two hr later the cells were harvested by centrifugation, washed and exposed to TCE in sealed vials with air headspaces.
Example 3: Isolation of a Tn5 Induced Toluene Monooxygenase Mutant of P. Cepacia G4
A method was developed for the isolation of transposon induced tomA mutants: Transposon mutagenesis was carried by a triparental mating: E. coli JM109 (pRZ102) (Jorgensen, R.A., S.J. Rothstein, and W.S. Reznikoff. 1979. Molec. Genet. 177:65-72) X E. coli JM109 (pRK2013) (Figurski, D.H., and D.R. Helinski. 1979. Proc. Natl. Acad. Sci. USA. 76:1648-1652) X P. cepacia G4. Selection for P. cepacia G4 containing a transposed copy of Tn5 was accomplished by growth of the mating mixture on basal salts medium containing 20 mM sodium lactate and 50 μg/ml kanamycin sulfate. Exposure to toluene vapor induced the requisite enzymes for toluene catabolism.
Colonies were transferred from the surface of the plate to nitrocellulose filters (0.45 μ pore size, Schliecher and Schuell, Keene, NH) previously soaked in an aqueous solution of 5mM TFMP and air dried. Mutants tomA and tomB (i.e. those lacking the toluene monooxygenase and catechol dioxygenase respectively) are easily differentiated as colorless colonies among a background of yellow wild type colonies. The two mutant types are readily distinguishable from one another as the catechol-2,3-dioxygenase mutant (tomB) turns brown in (>12Hr) basal salts media containing 20 mM sodium lactate and 2mM phenol (due to the accumulation and subsequent auto- oxidation of catechol). Mutants lacking toluene monoxygenase (tomA) do not.
Incorporation of TFMP in solid media was not sufficient to determine a single colony response as the color development required several minutes over which time the yellow product diffused throughout the plate. The nitrocellulose membrane lift technique was developed in response to this limitation. Colonies transferred to its surface immediately begin desiccation.
Any water soluble yellow product produced by that colony does not diffuse away. The result is a distinct yellow coloration of all colonies capable of transforming TFMP to the yellow product.
Using this technique the transposon mutant, P. cepacia G4 5223 was isolated. This mutant class (typified by G4100) lacked the ability to transform
TFMP and to degrade TCE.
Example 4: Procedure for Isolation of a Constitutive TCE Degrader
Transposon (Tn5) mutants of tomA were inoculated by patching to basal salts plates containing 2 mM phenol as the sole carbon source. Rare colonies arising were picked to basal salts medium containing 20mM sodium lactate as the sole carbon source. These colonies were in turn pulled to nitrocellulose discs impregnated with TFMP (Example 3) and compared to wild type P. cepacia G4 similarly grown on this non-inducing medium. Colonies that became yellow were picked as potentially constitutive for tomA and tomB gene products. In this way P. cepacia strain G4 5223 Phe(l) was isolated.
Table 4: TCE degradation without inducer
aMean TCE concentration of triplicate samples ± standard deviation after overnight incubation with the indicated strains (at a cell density equivalent to an A ,,,, = 0.2).
Table 5: Enzyme induction vs. constitutivity
The genetic stability of the invention strain was assessed by growing the cells under non-selective (i.e. basal salts medium with sodium lactate at 20 mM as the sole carbon source) and under selective conditions (i.e. the same
medium containing in addition 50 μg kanamycin sulphate/ml) through serially diluted batch cultures, allowing 10 generations per transfer. Following the accumulation of ca. 100 generations, the resulting population of cells was tested for kanamycin resistance (in the non-selective group) and the ability to constitutively transform TFMP to a yellow product (both groups):
Table 6: Genetic Stability
Lactate-grown colonies were picked to lactate plates containing 50μg/ml kanamycin. Those from 100 generations without selection exhibited 100% kanamycin resistance (150/150) as did those taken from kanamycin growth selection (75/75).
All colonies maintained tomA constitutivity under either growth condition (as demonstrated by pulling colonies to TFMP -impregnated nitrocellulose).
Example 5: TCE Degradation Under Ranges of Physical Conditions
In order to assess the capacity for P. cepacia G45223 Phe(l) to degrade TCE under anticipated ranges of environmental conditions the effects of oxygen concentration, pH, temperature and salinity were determined using a no air headspace TCE degradation assay (Folsom, B.R., P . Chapman, and P.H. Pritchard. 1990. Appl. Environ. Microbiol. 56:1279-1285) that mimicked a contaminated aquifer in that no gas headspaces were present. Unless otherwise noted in the salinity effect determinations, the liquid medium was the
basal salts medium buffered with Tris-HCl rather than phosphate. The results are shown in Figures 4a, 4b, 4c and 4d.
Example 6: Contitutive Degradation of 1.1-Dichloroethylene. cis-1.2- Dichloroethylene. and trans-1.2-Dichloroethylene
The range of chlorinated aliphatic substrates acted upon by P. cepacia G4 5223 Phe(l) was determined by the ability of cells to degrade 10μM TCE, 1,1-Dichloroethylene, cis-l,2-Dichloroethylene, trans-L2-Dichloroethylene and tetrachloroethylene in 2 ml of basal salts medium without additional carbon sources in 10 ml Teflon lined vessels during an overnight incubation at 24 degrees C. Triplicate samples were analyzed by gas chromatography for appearance of detectable products as well as disappearance of parent compounds: Table 7: Chloroaliphatic substrates of P. cepacia G4 5223 Phef 1.
aPercent substrate remaining as compared to uninoculated controls, abbreviations: 1,1-DCE, 1,1-Dichloroethylene; cis-l,2-DCE, cis-1,2- Dichloroethylene; trans.-l,2-DCE, trans-l,2-Dichloroethylene; TCE, Trichloroethylene; PCE, Perchloroethylene; ND, Not Detectable. Starting concentration was 10 μM for all substrates. Mindicates that a metabolite was detected using gas chromatography.
Claims
A process for degrading hazardous chemicals selected from the group consisting of chloroaliphatic and aromatic chemicals which comprises contacting said hazardous chemicals with an effective degrading amount of the bacterium Pseudomonas cepacia G4 5223 Phe(l), or mutants thereof which retain the parental property of being constitutive for the degradation of said hazardous chemicals.
2. The process, according to claim 1, wherein said hazardous chemicals are selected from the group consisting of trichloroethylene, 1,1- dichloroethylene, cis-1,2 dichloroethylene, trans-l,2-dichloroethylene, vinyl chloride, toluene, phenol, o-cresol, m-cresol, o-xylene, and benzene.
3. The process, according to claim 1, wherein said hazardous chemicals are degraded in situ or in a bioreactor.
4. The process, according to claim 3, wherein said m situ degradation is selected from the group consisting of contaminated aquifers, landfills, industrial sites contaminated with hazardous chemicals, and hazardous chemicals waste collection areas.
5. Pseudomonas cepacia G4 5223 Phe(l), a microbe which has the property of being constitutive for the degradation of hazardous chemicals selected from the group consisting of chloroaliphatic and aromatic chemicals.
6. Enzyme(s) obtainable from extracts of the microbe defined in claim 5, wherein said enzyme(s) has the property of degrading hazardous chemicals selected from the group consisting of chloroaliphatic and aromatic chemicals.
7. Gene(s) obtainable from the microbe defined in claim 5, wherein said gene(s) encode enzyme(s) having the property of degrading hazardous chemicals selected from the group consisting of chloroaliphatic and aromatic chemicals.
8. A process for degrading hazardous chemicals in situ or in a bioreactor, wherein said hazardous chemicals are selected from the group consisting of chloroaliphatic and aromatic chemicals, which comprises contacting said hazardous chemicals with an effective degrading amount of a recombinant microbe comprising a gene(s) obtainable from the microbe defined in claim 5, wherein said gene(s) encodes enzyme(s) having the property of degrading hazardous chemicals selected from the group consisting of chloroaliphatic and aromatic chemicals.
9. The process, according to claim 8, wherein said hazardous chemicals are selected from the group consisting of trichloroethylene, 1, 1- dichloroethylene, cis-1,2 dichloroethylene, trans-l,2-dichloroethylene, vinyl chloride, toluene, phenol, o-cresol, m-cresol, o-xylene, and benzene.
10. The process, according to claim 8, wherein said hazardous chemicals are degraded in situ or in a bioreactor.
11. The process, according to claim 10, wherein said in situ degradation is selected from the group consisting of contaminated aquifers, landfills, industrial sites contaminated with hazardous chemicals, and hazardous chemicals waste collection areas.
12. A process for degrading hazardous chemicals in situ or in a bioreactor, wherein said hazardous chemicals are selected from the group consisting of chloroaliphatic and aromatic chemicals, which comprises contacting said hazardous chemicals with an effective degrading amount of an enzyme(s) produced by the microbe defined in claim 5, wherein said enzyme(s) has the property of degrading hazardous chemicals selected from the group consisting of chloroaliphatic and aromatic chemicals.
13. A process for isolating transposon induced tomA mutants of Pseudomonas cepacia G4 which comprises: (a) transposon mutagenesis by a triparental mating comprising E. coli JM109 (pRZ102), E. co]i JM109 (pRZ2013) and P. cepacia: (b) selection for P. cepacia colonies containing a transposed copy of Tn5 by growth of the mating mixture on basal salts medium comprising sodium lactate and kanamycin sulfate; (c) transferring selected P. cepacia colonies of (b) to nitrocellulose filters previously soaked in an aqueous solution of TFMP and air dried; and, (d) isolating P. cepacia G4 5223 which lacks the ability to transform TFMP and to degrade TCE.
14. A process for isolating a constitutive P. cepacia G4 TCE degrader which comprises: (a) inoculating transposon mutants of tomA by patching to basal salts plates comprising phenol as the sole carbon source; (b) picking rare bacterial colonies to basal salts medium containing sodium lactate as the sole carbon source; (c) pulling said rare bacterial colonies to nitrocellulose discs impregnated with TFMP; and, (d) isolating bacterial colonies that turned yellow.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69471891A | 1991-05-02 | 1991-05-02 | |
US694,718 | 1996-08-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1992019738A1 true WO1992019738A1 (en) | 1992-11-12 |
Family
ID=24789997
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1992/003515 WO1992019738A1 (en) | 1991-05-02 | 1992-04-28 | Microbial degradation of trichloroethylene, dichloroethylenes and aromatic pollutants |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO1992019738A1 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0611729A1 (en) * | 1993-02-18 | 1994-08-24 | Canon Kabushiki Kaisha | Method for biodegrading trichloroethylene and method for biodegrading chlorinated organic compound by microorganisms |
EP0567102A3 (en) * | 1992-04-22 | 1994-11-23 | Canon Kk | Method of biologically decomposing phenol or furan compounds by microorganisms. |
EP0730027A3 (en) * | 1995-02-28 | 1997-09-03 | Canon Kk | Mutant microorganismexpressing oxygenase, processes of degrading organic compounds and remediation of the environment, using it |
WO1997040136A1 (en) * | 1996-04-22 | 1997-10-30 | Toyota Jidosha Kabushiki Kaisha | Microorganisms that decompose halogenated hydrocarbons and their use |
US5854059A (en) * | 1996-04-11 | 1998-12-29 | Canon Kabushiki Kaisha | Biodegradation of an organic compound and process for upgrading the environment by removing the aforesaid compound |
US5863789A (en) * | 1993-09-30 | 1999-01-26 | Canon Kabushiki Kaisha | Microorganism-holding carrier and method for remediation of soil employing the carrier |
EP0822253A3 (en) * | 1996-08-01 | 1999-01-27 | Canon Kabushiki Kaisha | Novel microbial strain, method for biodegrading organic compounds and method for environmental remediation |
EP0822252A3 (en) * | 1996-08-01 | 1999-01-27 | Canon Kabushiki Kaisha | Microbial strains, method for biodegrading organic compounds and method for environmental remediation |
US6004772A (en) * | 1995-02-28 | 1999-12-21 | Canon Kabushiki Kaisha | Oxygenase expressing microorganism strain JM1 (FERM BP-5352) for degrading organic compounds without an inducer |
US6096530A (en) * | 1992-04-22 | 2000-08-01 | Canon Kabushiki Kaisha | Pseudomonas cepacia strain isolated from termite intestines that degrades trichlorethylene and furan compounds |
WO2001059095A1 (en) * | 2000-02-14 | 2001-08-16 | Japan Science And Technology Corporation | Method of environmental purification or processing of harmful materials |
US6472191B1 (en) | 1998-12-03 | 2002-10-29 | Canon Kabushiki Kaisha | Dna fragment carrying toluene monooxygenase gene, recombinant plasmid, transformed microorganism, method for degrading chlorinated aliphatic hydrocarbon compounds and aromatic compounds, and method for environmental remediation |
JP3416262B2 (en) | 1994-06-07 | 2003-06-16 | キヤノン株式会社 | Gas phase contamination TCE purification method |
US6864074B2 (en) | 1998-10-30 | 2005-03-08 | Canon Kabushiki Kaisha | Dna fragment carrying toluene monooxygenase gene, recombinant plasmid, transformed microorganism, method for degrading chlorinated aliphatic hydrocarbon compounds and aromatic compounds, and method for environmental remediation |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4925802A (en) * | 1988-12-21 | 1990-05-15 | Ecova Corporation | Method for stimulating biodegradation of halogenated aliphatic hydrocarbons |
-
1992
- 1992-04-28 WO PCT/US1992/003515 patent/WO1992019738A1/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4925802A (en) * | 1988-12-21 | 1990-05-15 | Ecova Corporation | Method for stimulating biodegradation of halogenated aliphatic hydrocarbons |
Non-Patent Citations (4)
Title |
---|
APPLIED AND ENVIRONMENTAL MICROBIOLOGY vol. 53, no. 5, May 1987, WASHINGTON DC US pages 949 - 954; M. NELSON ET AL.: 'Biodegradation of trichloroethylene and involvement of an aromatic biodegradative pathway' * |
ARCHIVES OF MIROBIOLOGY vol. 149, 1988, pages 188 - 197; K. ENGESSER ET AL.: 'Bacterial metabolism of side chain fluorinated aromatics' * |
BIOTECHNOLOGY vol. 7, no. 3, March 1989, NEW YORK US pages 282 - 285; B. WINTER ET AL.: 'Efficient degradation of trichloroethylene by a recombinant Escherichia coli' * |
JOURNAL OF GENERAL MICROBIOLOGY vol. 131, no. 9, 1 September 1985, LONDON, GB pages 2449 - 2467; C. BOUCHER ET AL.: 'Transposon mutagenesis of Pseudomonas solanacearum: Isolation of Tn5-induced avirulent mutants' * |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0567102A3 (en) * | 1992-04-22 | 1994-11-23 | Canon Kk | Method of biologically decomposing phenol or furan compounds by microorganisms. |
US6096530A (en) * | 1992-04-22 | 2000-08-01 | Canon Kabushiki Kaisha | Pseudomonas cepacia strain isolated from termite intestines that degrades trichlorethylene and furan compounds |
EP0611729A1 (en) * | 1993-02-18 | 1994-08-24 | Canon Kabushiki Kaisha | Method for biodegrading trichloroethylene and method for biodegrading chlorinated organic compound by microorganisms |
US5993658A (en) * | 1993-02-18 | 1999-11-30 | Canon Kabushiki Kaisha | Method for biodegrading trichloroethylene and method for biodegrading chlorinated organic compound by microorganisms |
US5863789A (en) * | 1993-09-30 | 1999-01-26 | Canon Kabushiki Kaisha | Microorganism-holding carrier and method for remediation of soil employing the carrier |
JP3416262B2 (en) | 1994-06-07 | 2003-06-16 | キヤノン株式会社 | Gas phase contamination TCE purification method |
EP0730027A3 (en) * | 1995-02-28 | 1997-09-03 | Canon Kk | Mutant microorganismexpressing oxygenase, processes of degrading organic compounds and remediation of the environment, using it |
US6004772A (en) * | 1995-02-28 | 1999-12-21 | Canon Kabushiki Kaisha | Oxygenase expressing microorganism strain JM1 (FERM BP-5352) for degrading organic compounds without an inducer |
US5854059A (en) * | 1996-04-11 | 1998-12-29 | Canon Kabushiki Kaisha | Biodegradation of an organic compound and process for upgrading the environment by removing the aforesaid compound |
US5998198A (en) * | 1996-04-22 | 1999-12-07 | Toyota Jidosha Kabushiki Kaisha | Microorganisms that decompose halogenated hydrocarbons and their use |
WO1997040136A1 (en) * | 1996-04-22 | 1997-10-30 | Toyota Jidosha Kabushiki Kaisha | Microorganisms that decompose halogenated hydrocarbons and their use |
US5945331A (en) * | 1996-08-01 | 1999-08-31 | Canon Kabushiki Kaisha | Microorganisms, and method for biodegradation of organic compounds and method for environmental remediation |
US5962305A (en) * | 1996-08-01 | 1999-10-05 | Canon Kabushiki Kaisha | Microbial strain, method for biodegrading organic compounds and method for environmental remediation |
EP0822252A3 (en) * | 1996-08-01 | 1999-01-27 | Canon Kabushiki Kaisha | Microbial strains, method for biodegrading organic compounds and method for environmental remediation |
JP3347596B2 (en) | 1996-08-01 | 2002-11-20 | キヤノン株式会社 | A novel microorganism, a method for biodegrading aromatic compounds and / or organic chlorine compounds, and a method for purifying a medium |
EP0822253A3 (en) * | 1996-08-01 | 1999-01-27 | Canon Kabushiki Kaisha | Novel microbial strain, method for biodegrading organic compounds and method for environmental remediation |
US6864074B2 (en) | 1998-10-30 | 2005-03-08 | Canon Kabushiki Kaisha | Dna fragment carrying toluene monooxygenase gene, recombinant plasmid, transformed microorganism, method for degrading chlorinated aliphatic hydrocarbon compounds and aromatic compounds, and method for environmental remediation |
US6472191B1 (en) | 1998-12-03 | 2002-10-29 | Canon Kabushiki Kaisha | Dna fragment carrying toluene monooxygenase gene, recombinant plasmid, transformed microorganism, method for degrading chlorinated aliphatic hydrocarbon compounds and aromatic compounds, and method for environmental remediation |
US6858417B2 (en) | 1998-12-03 | 2005-02-22 | Canon Kabushiki Kaisha | Dna fragment carrying toluene monooxygenase, gene, recombinant plasmid, transformed microorganism, method for degrading chlorinated aliphatic hydrocarbon compounds and aromatic compounds, and method for environmental remediation |
WO2001059095A1 (en) * | 2000-02-14 | 2001-08-16 | Japan Science And Technology Corporation | Method of environmental purification or processing of harmful materials |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Shields et al. | Selection of a Pseudomonas cepacia strain constitutive for the degradation of trichloroethylene | |
US4493895A (en) | Microbial degradation of obnoxious organic wastes into innocuous materials | |
Mrozik et al. | Bacterial degradation and bioremediation of polycyclic aromatic hydrocarbons. | |
US4477570A (en) | Microbial degradation of obnoxious organic wastes into innocucous materials | |
Bedard et al. | Extensive degradation of Aroclors and environmentally transformed polychlorinated biphenyls by Alcaligenes eutrophus H850 | |
US4925802A (en) | Method for stimulating biodegradation of halogenated aliphatic hydrocarbons | |
US5543317A (en) | Microbial degradation of trichloroethylene dichloroethylenes and aromatic pollutants | |
Spain et al. | Degradation of 1, 4-dichlorobenzene by a Pseudomonas sp | |
Focht | Microbial degradation of chlorinated biphenyls | |
US4959315A (en) | Biodegradation of chloroethylene compounds | |
Krooneman et al. | Isolation of Alcaligenes sp. strain L6 at low oxygen concentrations and degradation of 3-chlorobenzoate via a pathway not involving (chloro) catechols | |
Wongbunmak et al. | BTEX-and naphthalene-degrading bacterium Microbacterium esteraromaticum strain SBS1-7 isolated from estuarine sediment | |
McClay et al. | Induction of toluene oxidation activity in Pseudomonas mendocina KR1 and Pseudomonas sp. strain ENVPC5 by chlorinated solvents and alkanes | |
WO1992019738A1 (en) | Microbial degradation of trichloroethylene, dichloroethylenes and aromatic pollutants | |
Kahlon | Biodegradation and bioremediation of organic chemical pollutants by Pseudomonas | |
EP0822252A2 (en) | Microbial strains, method for biodegrading organic compounds and method for environmental remediation | |
Sun et al. | Trichloroethylene mineralization in a fixed‐film bioreactor using a pure culture expressing constitutively toluene ortho‐monooxygenase | |
Halden et al. | Biodegradation of dioxin-related compounds: a review | |
US6537797B1 (en) | Compositions and methods useful in bioremediation of polychlorinated biphenyls | |
Boyle | The environmental microbiology of chlorinated aromatic decomposition | |
US20170151593A1 (en) | Method for scavenging aromatic hydrocarbons, crude petroleum and/or a petroleum refined product | |
Karns et al. | Microbial biodegradation of 2, 4, 5-trichlorophenoxyacetic acid and chlorophenols | |
US5958757A (en) | Biological conversion of organic compounds | |
Adebusoye et al. | Extensive biodegradation of polychlorinated biphenyls in Aroclor 1242 and electrical transformer fluid (Askarel) by natural strains of microorganisms indigenous to contaminated African systems | |
US5578474A (en) | Process for culturing recombinant microorganisms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA NO |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |